<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02285946</url>
  </required_header>
  <id_info>
    <org_study_id>6032</org_study_id>
    <nct_id>NCT02285946</nct_id>
  </id_info>
  <brief_title>Comparison of Supine to Prone Position During Major Spinal Surgery</brief_title>
  <acronym>MRA-RACHIS</acronym>
  <official_title>Alveolar Recruitment Maneuvers: Comparison of Supine to Prone Position During Major Spinal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During mechanical ventilation, the alveolar recruitment maneuver (ARM) is to apply a positive&#xD;
      end-expiratory pressure (PEEP) (generally 30 cm H2O) for a period of at least 30 seconds. The&#xD;
      realization of MRA is one of three main elements of mechanical ventilation called&#xD;
      &quot;protective&quot;. This ventilatory strategy, originally described for the ventilation of acute&#xD;
      respiratory distress syndrome (ARDS), and pulmonary and during abdominal surgery is based on&#xD;
      a decrease tidal volumes, optimization of PEEP and the realization of MRA. Protective&#xD;
      ventilation limit the occurrence of atelectasis, the surdistentions and, ultimately,&#xD;
      significantly decreases postoperative complications.&#xD;
&#xD;
      The MRA is currently recommended in the &quot;major&quot; surgery. Most spine surgery (eg&#xD;
      transpedicular fixation) used in this definition, the MRA are indicated and now commonly&#xD;
      used. This type of surgery requires further positioning the patient in the prone position&#xD;
      (DV). The DV modifies the compliance of the chest respiratory characteristics and changes&#xD;
      (increase in insufflation pressure) and hemodynamic (decreased venous return) of the patient.&#xD;
&#xD;
      Respiratory and haemodynamic effects of MRA made VIS at major spine surgery are not known.&#xD;
      The aim of this observational study, non-interventional, is to compare the hemodynamic and&#xD;
      respiratory effects of MRA performed in DV to those of MRA performed in the prone position&#xD;
      (DD).&#xD;
&#xD;
      The investigators hypothesis is that the respiratory and hemodynamic consequences of MRA&#xD;
      performed in DV is different from those conducted in DD. A better understanding of&#xD;
      hemodynamic and respiratory characteristics of MRA performed in DV would provide a more&#xD;
      tailored to this type of surgery respiratory optimization strategy and reduce respiratory&#xD;
      complications of this surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">November 2014</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The hemodynamic and respiratory data are collected before, during and after the completion of 3 ARM (alveolar recruitment maneuver):</measure>
    <time_frame>T1: ARM (in a supine position) (before setting prone position); T2: ARM (prone position) ; T3: ARM at acute respiratory distress syndrome [ARDS] (end of intervention, after supine position); (* At the end of ARM, only hemodynamic data are collected)</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Osteotomies</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>major spine surgery</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient operated major spine surgery, including:&#xD;
&#xD;
          -  The transpedicular osteotomies&#xD;
&#xD;
          -  Tumor spinal surgery (sarcoma, osteosarcoma) or metastatic&#xD;
&#xD;
          -  Degenerative spinal surgery on multiple vertebral levels and degraded land&#xD;
&#xD;
          -  Surgery of scoliosis&#xD;
&#xD;
          -  Recovery of spinal surgery on several levels&#xD;
&#xD;
          -  Sepsis spinal presumed origin&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Adult patient&#xD;
&#xD;
        Patient operated major spine surgery, including:&#xD;
&#xD;
          -  The transpedicular osteotomies&#xD;
&#xD;
          -  Tumor spinal surgery (sarcoma, osteosarcoma) or metastatic&#xD;
&#xD;
          -  Degenerative spinal surgery on multiple vertebral levels and degraded land&#xD;
&#xD;
          -  Surgery of scoliosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to give informed patient information (eg difficulty of understanding)&#xD;
&#xD;
          -  Patient under guardianship - Patient pregnant or during lactation - Detainees or under&#xD;
             judicial protection.&#xD;
&#xD;
          -  contraindications to MRA: emphysema, pneumothorax, major hypovolemia, hemodynamic&#xD;
             instability defined as systolic blood pressure below 90 mmHg or tachycardia greater&#xD;
             than 110 bpm.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>COLLANGE Olivier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Strasbourg University Hospital, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>COLLANGE Olivier, MD</last_name>
    <phone>33369551551</phone>
    <email>olivier.collange@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kieffer Vianney, MD</last_name>
    <phone>33369551551</phone>
    <email>vianney.kieffer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service D'Anesthesiologie - Nhc</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Collonge Olivier, MD</last_name>
      <phone>33369551551</phone>
      <email>olivier.collange@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service d'Anesthesiologie - NHC</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier COLLONGE, MD</last_name>
      <phone>33 3 69 55 51 51</phone>
      <email>olivier.collange@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Vianney KIEFFER, MD</last_name>
      <phone>33 3 69 55 51 51</phone>
      <email>vianney.kieffer@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Olivier COLLONGE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vianney KIEFFER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>October 2, 2014</study_first_submitted>
  <study_first_submitted_qc>November 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2014</study_first_posted>
  <last_update_submitted>May 18, 2017</last_update_submitted>
  <last_update_submitted_qc>May 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

